Suppr超能文献

比较在产房和新生儿病房中对早产儿进行微创表面活性剂给药的效果。

Comparison of Outcomes of Less Invasive Surfactant Administration in Prematurely Born Infants in the Delivery Suite and the Neonatal Unit.

机构信息

Neonatal Intensive Care Centre, St. George's University Hospitals NHS Foundation Trust, London, United Kingdom.

St George's University of London, London, United Kingdom.

出版信息

Am J Perinatol. 2024 May;41(S 01):e2674-e2678. doi: 10.1055/a-2142-9434. Epub 2023 Jul 27.

Abstract

OBJECTIVE

This study aimed to compare outcomes of infants who received less invasive surfactant administration (LISA) in the delivery suite (LISA-DS) with those who received LISA on the neonatal unit (LISA-NNU).

STUDY DESIGN

A prospective cohort study was undertaken of all infants who received LISA in a single center. Clinical outcomes included admission temperature, the need for intubation, durations of invasive and noninvasive ventilation, length of hospital stay and the incidences of bronchopulmonary dysplasia (BPD), intraventricular hemorrhage (IVH), retinopathy of prematurity (ROP), and requirement for home oxygen were compared between the two groups as were complications of the procedure.

RESULTS

The 54 LISA-DS infants had similar gestational ages and birth weights to the 26 LISA-NNU infants ( = 0.732, 0.928, respectively). There were no significant differences between the admission temperatures (median [range]: 36.8 [36-38.7] vs. 36.8°C [36.4-37.7];  = 0.451) or need for intubation in less than 72 hours of birth (28 vs. 23%,  = 0.656). The durations of invasive ventilation (median: 2 [0-65] vs. 1 [0-35] days;  = 0.188) and noninvasive ventilation (median: 37 [24-81] vs. 37 [3-225] days;  = 0.188) and the incidences of BPD ( = 0.818), IVH ( = 0.106), ROP ( = 0.526), and home oxygen requirement ( = 0.764) were similar. The percentage of successful first attempts with LISA (63 vs. 70%,  = 0.816) or associated with hypoxia episodes (32 vs. 42%,  = 0.194) did not differ significantly by site of administration.

CONCLUSION

The outcomes of LISA performed on the DS were similar to those of LISA performed on the NNU.

KEY POINTS

· Prematurely born infants who received LISA in the DS had comparable clinical outcomes to infants who received LISA on NNU.. · No significant differences in admission temperature was noticed in infants who received LISA, in DS versus NNU..

摘要

目的

本研究旨在比较在产房(LISA-DS)接受微创表面活性剂给药(LISA)的婴儿与在新生儿重症监护病房(LISA-NNU)接受 LISA 的婴儿的结局。

研究设计

对在单中心接受 LISA 的所有婴儿进行前瞻性队列研究。临床结局包括入院体温、插管需求、有创和无创通气持续时间、住院时间以及支气管肺发育不良(BPD)、脑室内出血(IVH)、早产儿视网膜病变(ROP)和家庭氧疗需求的发生率,并比较两组之间的程序并发症。

结果

54 例 LISA-DS 婴儿的胎龄和出生体重与 26 例 LISA-NNU 婴儿相似(=0.732,0.928)。入院体温(中位数[范围]:36.8 [36-38.7] vs. 36.8°C [36.4-37.7];=0.451)或出生后 72 小时内插管的需求(28 比 23%,=0.656)均无显著差异。有创通气(中位数:2 [0-65] vs. 1 [0-35] 天;=0.188)和无创通气(中位数:37 [24-81] vs. 37 [3-225] 天;=0.188)的持续时间以及 BPD(=0.818)、IVH(=0.106)、ROP(=0.526)和家庭氧疗需求(=0.764)的发生率相似。LISA 首次尝试成功率(63 比 70%,=0.816)或与缺氧发作相关(32 比 42%,=0.194)的比例在不同的给药部位之间无显著差异。

结论

在产房进行 LISA 的结果与在新生儿重症监护病房进行 LISA 的结果相似。

关键点

· 在产房接受 LISA 的早产儿的临床结局与在新生儿重症监护病房接受 LISA 的婴儿相似。· 在接受 LISA 的婴儿中,在产房和新生儿重症监护病房之间,入院体温无显著差异。

相似文献

4
Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China.经鼻持续气道正压通气与肺表面活性物质联合鼻塞式气道正压通气治疗早产儿呼吸窘迫综合征的临床疗效比较 目的:探讨经鼻持续气道正压通气(NCPAP)与肺表面活性物质(PS)联合鼻塞式气道正压通气(CPAP)治疗早产儿呼吸窘迫综合征(NRDS)的临床疗效。方法:选择 2019 年 1 月至 2020 年 12 月在我院接受治疗的 86 例 NRDS 早产儿作为研究对象,按照随机数字表法分为观察组和对照组,每组 43 例。观察组给予 NCPAP 联合 PS 治疗,对照组给予 CPAP 联合 PS 治疗。比较两组患儿的临床疗效、血气指标、机械通气时间、住院时间及不良反应发生情况。结果:观察组患儿的总有效率为 95.35%,明显高于对照组的 76.74%(P<0.05)。治疗后,观察组患儿的 PaO2、SaO2 水平明显高于对照组,PaCO2 水平明显低于对照组(P<0.05)。观察组患儿的机械通气时间和住院时间明显短于对照组(P<0.05)。观察组患儿的不良反应总发生率为 4.65%,明显低于对照组的 18.60%(P<0.05)。结论:NCPAP 联合 PS 治疗 NRDS 早产儿的临床疗效优于 CPAP 联合 PS 治疗,能有效改善血气指标,缩短机械通气时间和住院时间,降低不良反应发生率。
BMC Pulm Med. 2022 Dec 5;22(1):462. doi: 10.1186/s12890-022-02270-x.
9
Less Invasive Surfactant Administration in Very Prematurely Born Infants.极早产儿的微创表面活性剂给药
AJP Rep. 2021 Jul;11(3):e119-e122. doi: 10.1055/s-0041-1735632. Epub 2021 Sep 22.

本文引用的文献

1
Outcomes following less-invasive-surfactant-administration in the delivery-room.产房内使用微创肺表面活性剂给药的结果。
Early Hum Dev. 2022 Apr;167:105562. doi: 10.1016/j.earlhumdev.2022.105562. Epub 2022 Feb 26.
4
Less Invasive Surfactant Administration in Very Prematurely Born Infants.极早产儿的微创表面活性剂给药
AJP Rep. 2021 Jul;11(3):e119-e122. doi: 10.1055/s-0041-1735632. Epub 2021 Sep 22.
8
UK survey of less invasive surfactant administration.英国微创表面活性剂给药调查。
Arch Dis Child Fetal Neonatal Ed. 2019 Sep;104(5):F567. doi: 10.1136/archdischild-2018-316466. Epub 2019 Feb 11.
9
Sedation during minimal invasive surfactant therapy: a randomised controlled trial.微创表面活性剂治疗期间的镇静:一项随机对照试验。
Arch Dis Child Fetal Neonatal Ed. 2019 Jul;104(4):F378-F383. doi: 10.1136/archdischild-2018-315015. Epub 2018 Aug 1.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验